HRX 2022: GPX Inc: Novel AI Algorithmic Blood Biomarker Monitoring

HRX 22 - GPX Inc. CEO Javier Echenique (GPX Inc., Boston, MA, US) joins us to discuss CardioID - a novel AI Algorithm-based "bloodless blood test" that uses NT-proBNP biomarkers in patient

YMJ :: Yonsei Medical Journal

Antioxidants, Free Full-Text

Digital Health

Sensors, Free Full-Text

先端AIのベンチャーが登場するSXSW2023のピッチファイナリスト

先端AIのベンチャーが登場するSXSW2023のピッチファイナリスト

PDF) Automated Retinal Imaging System for Detecting Cardiac Abnormalities Using Cup to Disc Ratio

SciELO - Brasil - Early Initiation of Extracorporeal Blood

Labbook 2022